Antagonist - PDFSEARCH.IO - Document Search Engine

Antagonist
Results: 956

#	Item
381	Cardiokine Biopharma, LLC Lixivaptan Briefing Document NDA 203,009 Page 1 of 61 Add to Reading List Source URL: www.fda.gov Language: English Electrolyte disturbances Amides Organochlorides Diuretics Lixivaptan Hyponatremia Syndromes Vasopressin receptor antagonist Hypernatremia Medicine Biology Chemistry
382	NIAMS IRPartners Fall/Winter[removed]A newsletter for Add to Reading List Source URL: niams.nih.gov Language: English - Date: 2011-10-31 10:43:00 Arthritis Rheumatology Connective tissue diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases NIH Intramural Research Program Autoimmune diseases Anakinra Interleukin 1 receptor antagonist Periodic fever syndrome Health Medicine National Institutes of Health
383	Special Issue: Call for Papers Editor-in-Chief: Adam J. Gordon, MD MPH FACP FASAM In cooperation with Deadlines Add to Reading List Source URL: www.integration.samhsa.gov Language: English Opioid agonist treatment Alcohols Morphinans Opioid Ethers Phenols Opioid antagonist Chemistry Organic chemistry Substance dependence
384	Aetna Precertification Notification 503 Sunport Lane, Orlando, FL[removed]Phone: [removed]FAX: [removed] Add to Reading List Source URL: www.aetna.com Language: English - Date: 2013-02-06 06:13:43 Organic chemistry Ketones Vomiting Lactams Oncology 5-HT3 antagonist Ondansetron Granisetron Postoperative nausea and vomiting Medicine Chemistry Antiemetics
385	Microsoft Word - CHC-B-PPC3-Element-A.doc Add to Reading List Source URL: www.champsonline.org Language: English - Date: 2011-12-21 15:59:14 Organ failure Antihypertensive drug Kidney diseases Blood pressure Thiazide Essential hypertension Prehypertension Angiotensin II receptor antagonist Complications of hypertension Anatomy Hypertension Health
386	Microsoft Word - FS[removed]PPIs - Duration of use limit[removed]doc Add to Reading List Source URL: www.hca.wa.gov Language: English - Date: 2013-01-25 19:09:49 Health Benzimidazoles Pyridines Sulfoxides Ranitidine Gastroesophageal reflux disease Peptic ulcer Omeprazole H2 antagonist Medicine Gastroenterology Proton pump inhibitors
387	FDA/FCHR Collaborative Public Meeting on Long-term Safety Concerns Associated with CCR5 Antagonist Development May 31, 2006 DRAFT REPORT Written by John Fry; Edited by Veronica Miller, on behalf of all presenters and pan Add to Reading List Source URL: www.fda.gov Language: English - Date: 2007-04-20 08:28:23 Entry inhibitors Organic chemistry Chemokine receptors Organofluorides CCR5 Vicriviroc Monogram Biosciences HIV Antiretroviral drug HIV/AIDS Biology Chemistry
388	L. Steven Leshin: Pharmacology and Toxicology Add to Reading List Source URL: www.fda.gov Language: English Amines Eli Lilly and Company Pharmacology Anesthesia Dextropropoxyphene HERG Local anesthetic Receptor antagonist Analgesic Chemistry Medicine Organic chemistry
389	PLEASE NOTE THAT THIS ATTACHMENT IS A DRAFT REPORT OF A SERIES OF MEETINGS THAT WERE CONVENED OVER THE PERIOD OF MAY 2005 THROUGH MAY 2006 Add to Reading List Source URL: www.fda.gov Language: English - Date: 2007-04-20 08:28:22 Biology Organic chemistry Organofluorides Chemokine receptors CCR5 receptor antagonist CCR5 Maraviroc Antiretroviral drug HIV HIV/AIDS Entry inhibitors Chemistry
390	PowerPoint プレゼンテーション Add to Reading List Source URL: www.daiichisankyo.com Language: English - Date: 2014-09-21 22:39:50 Daiichi Sankyo Olmesartan Azor Prasugrel Pravastatin Angiotensin II receptor antagonist Warfarin Ranbaxy Laboratories Statin Chemistry Organic chemistry Ketones